APEIRON Biologics Competitors and Similar CompaniesClear all

APEIRON Biologics's competitors and similar companies include OxThera, KBP Biosciences, Abivax and Adagene.
APEIRON Biologics
APEIRON Biologics
APEIRON Biologics is a biotech company focused on the discovery and development of cancer immunotherapies.
OxThera
OxThera
OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate.
KBP Biosciences
KBP Biosciences
KBP is developing a pipeline of new chemical entities with known mechanisms of action in areas of unmet medical need in cardiovascular, infectious disease, respiratory, inflammatory and autoimmune diseases.
Abivax
Abivax
Abivax is a biotech company that mobilizes the body’s natural immune system to treat patients suffering from inflammatory diseases, infectious diseases, and cancer.
Adagene
Adagene
Adagene is an antibody discovery and development biotechnology company specializing in oncology immunotherapy.
Founding Date
Founding Date
2005
Founding Date
N/A
Founding Date
2007
Founding Date
2013
Founding Date
2012
Type
Type
Private
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Wien, AT HQ
Locations
Stockholm, SE HQ
Knoxville, US
Locations
Princeton, US HQ
Jinan Shi, CN
Locations
Paris, FR HQ
Montpellier, FR
Locations
Suzhou, CN HQ
San Diego, US
San Francisco, US
Employees
Employees
12
Employees
7
Employees
46
Employees
26
Employees
248
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
996.2 m
Valuation ($)
113.9 m
Twitter followers
Twitter followers
667
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
1.3 k
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
kr11m (FY, 2015)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$18.1m (FY, 2023)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
€4.6m (FY, 2023)
Gross profit
$21.6m (FY, 2023)
Net income
Net income
N/A
Net income
(kr37.8m) (FY, 2015)
Net income
N/A
Net income
(€147.7m) (FY, 2023)
Net income
($18.9m) (FY, 2023)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 53.3m
Total funding raised
$ 76m
Total funding raised
$ 13.5m
Total funding raised
$ 155m
For sources of this data, please see the company profile

View Company Profiles

OxThera
HQ
Stockholm, SE
Employees
7

OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate.

View company
KBP Biosciences
HQ
Princeton, US
Employees
46

KBP is developing a pipeline of new chemical entities with known mechanisms of action in areas of unmet medical need in cardiovascular, infectious disease, respiratory, inflammatory and autoimmune diseases.

View company
Abivax
HQ
Paris, FR
Employees
26

Abivax is a biotech company that mobilizes the body’s natural immune system to treat patients suffering from inflammatory diseases, infectious diseases, and cancer.

View company
Adagene
HQ
Suzhou, CN
Employees
248

Adagene is an antibody discovery and development biotechnology company specializing in oncology immunotherapy.

View company